The integrated production platform aims to produce and purify these proteins using a combination of engineered
microbial cell factories and flexible approaches for purification to accommodate different vaccines and future candidates.
To find out why, computational biologists came up with a computer model to predict how
microbial metabolism and cellular composition change as
cell size varies, using details about how much space a bacterium needs for its components — DNA, proteins, and the molecular
factories called ribosomes — to function.